Literature DB >> 25995533

A heterogeneous optimization algorithm for reacted singlet oxygen for interstitial PDT.

Timothy C Zhu1, Martin D Altschuler1, Yida Hu1, Ken Wang1, Jarod C Finlay1, Andreea Dimofte1, Keith Cengel1, Stephen M Hahn1.   

Abstract

Singlet oxygen (1O2) is the major cytotoxic agent for type II photodynamic therapy (PDT). The production of 1O2 involves the complex reactions among light, oxygen molecule, and photosensitizer. From universal macroscopic kinetic equations which describe the photochemical processes of PDT, the reacted 1O2 concentration, [1O2]rx, with cell target can be expressed in a form related to time integration of the product of 1O2 quantum yield and the PDT dose rate. The object of this study is to develop optimization procedures that account for the optical heterogeneity of the patient prostate, the tissue photosensitizer concentrations, and tissue oxygenation, thereby enable delivery of uniform reacted singlet oxygen to the gland. We use the heterogeneous optical properties measured for a patient prostate to calculate a light fluence kernel. Several methods are used to optimize the positions and intensities of CDFs. The Cimmino feasibility algorithm, which is fast, linear, and always converges reliably, is applied as a search tool to optimize the weights of the light sources at each step of the iterative selection. Maximum and minimum dose limits chosen for sample points in the prostate constrain the solution for the intensities of the linear light sources. The study shows that optimization of individual light source positions and intensities is feasible for the heterogeneous prostate during PDT. To study how different photosensitizer distributions as well as tissue oxygenation in the prostate affect optimization, comparisons of light fluence rate were made with measured distribution of photosensitizer in prostate under different tissue oxygenation conditions.

Entities:  

Keywords:  Prostate PDT; Singlet oxygen; optimization

Year:  2010        PMID: 25995533      PMCID: PMC4435729          DOI: 10.1117/12.842968

Source DB:  PubMed          Journal:  Proc SPIE Int Soc Opt Eng        ISSN: 0277-786X


  22 in total

1.  Speed and convergence properties of gradient algorithms for optimization of IMRT.

Authors:  Xiaodong Zhang; Helen Liu; Xiaochun Wang; Lei Dong; Qiuwen Wu; Radhe Mohan
Journal:  Med Phys       Date:  2004-05       Impact factor: 4.071

2.  Optimization of brachytherapy dose distributions by simulated annealing.

Authors:  R S Sloboda
Journal:  Med Phys       Date:  1992 Jul-Aug       Impact factor: 4.071

3.  A comprehensive mathematical model of microscopic dose deposition in photodynamic therapy.

Authors:  Ken Kang-Hsin Wang; Soumya Mitra; Thomas H Foster
Journal:  Med Phys       Date:  2007-01       Impact factor: 4.071

4.  Determination of in vivo light fluence distribution in a heterogeneous prostate during photodynamic therapy.

Authors:  Jun Li; Timothy C Zhu
Journal:  Phys Med Biol       Date:  2008-03-27       Impact factor: 3.609

5.  Optimization of physiological parameter for macroscopic modeling of reacted singlet oxygen concentration in an in-vivo model.

Authors:  Ken Kang-Hsin Wang; Theresa M Busch; Jarod C Finlay; Timothy C Zhu
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2009-02-18

6.  Updated results of a phase I trial of motexafin lutetium-mediated interstitial photodynamic therapy in patients with locally recurrent prostate cancer.

Authors:  Kosmas Verigos; Diana C Hsiung Stripp; Rosemarie Mick; Timothy C Zhu; Richard Whittington; Debbie Smith; Andreea Dimofte; Jarod Finlay; Theresa M Busch; Zelig A Tochner; S Malkowicz; Eli Glatstein; Stephen M Hahn
Journal:  J Environ Pathol Toxicol Oncol       Date:  2006       Impact factor: 3.567

7.  Explicit dosimetry for photodynamic therapy: macroscopic singlet oxygen modeling.

Authors:  Ken Kang-Hsin Wang; Jarod C Finlay; Theresa M Busch; Stephen M Hahn; Timothy C Zhu
Journal:  J Biophotonics       Date:  2010-06       Impact factor: 3.207

8.  Optical properties of human prostate at 732 nm measured in mediated photodynamic therapy.

Authors:  Timothy C Zhu; Andreea Dimofte; Jarod C Finlay; Diana Stripp; Theresa Busch; Jeremy Miles; Richard Whittington; S Bruce Malkowicz; Zelig Tochner; Eli Glatstein; Stephen M Hahn
Journal:  Photochem Photobiol       Date:  2005 Jan-Feb       Impact factor: 3.421

9.  Determination of the distribution of light, optical properties, drug concentration, and tissue oxygenation in-vivo in human prostate during motexafin lutetium-mediated photodynamic therapy.

Authors:  Timothy C Zhu; Jarod C Finlay; Stephen M Hahn
Journal:  J Photochem Photobiol B       Date:  2004-12-02       Impact factor: 6.252

10.  Optimization of light source parameters in the photodynamic therapy of heterogeneous prostate.

Authors:  Jun Li; Martin D Altschuler; Stephen M Hahn; Timothy C Zhu
Journal:  Phys Med Biol       Date:  2008-07-08       Impact factor: 3.609

View more
  2 in total

1.  Automatic interstitial photodynamic therapy planning via convex optimization.

Authors:  Abdul-Amir Yassine; William Kingsford; Yiwen Xu; Jeffrey Cassidy; Lothar Lilge; Vaughn Betz
Journal:  Biomed Opt Express       Date:  2018-01-30       Impact factor: 3.732

2.  Validation of combined Monte Carlo and photokinetic simulations for the outcome correlation analysis of benzoporphyrin derivative-mediated photodynamic therapy on mice.

Authors:  Karl W Beeson; Evgueni Parilov; Mary Potasek; Michele M Kim; Timothy C Zhu
Journal:  J Biomed Opt       Date:  2019-03       Impact factor: 3.170

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.